Isotechnika Pharma Inc IPHAF

RE: ISA: a day late and a dollar short.....teepee

[stockman6]

Teepee, you have stated several times that you view ISA to be a risky stock because it is in "very early stages of development". You say this about a company who had great Phase I results and is currently "progessing well" in Phase II trials. So let's look at this new "opportunity" that has you all exited and will beat ISA to market. From your message: "Once this drug is developed and deployed, it will belong to a $2 billion dollar US market, as reported by Goldman Sachs, and a multi-billion dollar market worldwide! " Are you serious? Which part of "Once this drug is developed....." can't you understand? In case Altius is reading I'll keep it really simple: THE DRUG DOESN'T EVEN EXIST YET. Real good pick Teevee, where can I sign up. P.S. LOL! Hey, I've got some land down in Mexico for sale. Once developed, it will be part of a $2 billion dollar resort complex! I'll e-mail you details, in 24 HOURS...........